Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,016 | -471 | -42,611 | -37,949 | 1,856 |
| Depreciation Amortization | 35,029 | 27,554 | 25,504 | 17,486 | 16,058 |
| Income taxes - deferred | -1,828 | N/A | N/A | N/A | N/A |
| Accounts receivable | -8,524 | -5,999 | -1,721 | -4,082 | -3,489 |
| Accounts payable and accrued liabilities | -1,822 | -573 | 5,712 | -350 | 8,966 |
| Other Working Capital | 9,730 | -10,857 | -2,574 | 22,279 | -23,319 |
| Other Operating Activity | 48,951 | 39,216 | 33,475 | 36,069 | 27,949 |
| Operating Cash Flow | $70,520 | $48,870 | $17,785 | $33,453 | $28,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,622 | N/A | -181,039 | -21,188 | 28,158 |
| PPE Investments | -10,159 | -14,514 | -19,266 | -24,709 | -40,295 |
| Net Acquisitions | -117,691 | -6,843 | -8,460 | -15,857 | -7,119 |
| Purchase Of Investment | -318,484 | -363,255 | -15,000 | N/A | N/A |
| Sale Of Investment | 319,468 | 405,188 | N/A | N/A | N/A |
| Investing Cash Flow | $-128,488 | $20,576 | $-223,765 | $-61,754 | $-19,256 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 345,000 | N/A | N/A |
| Debt Repayment | -571 | N/A | -118,193 | -4 | -1,467 |
| Common Stock Issued | 10,871 | 8,954 | 8,640 | 7,265 | 12,166 |
| Other Financing Activity | -6,630 | 0 | -11,285 | 0 | 0 |
| Financing Cash Flow | $3,670 | $8,954 | $224,162 | $7,261 | $10,699 |
| Beginning Cash Position | 132,526 | 54,126 | 35,944 | 56,984 | 37,520 |
| End Cash Position | 78,228 | 132,526 | 54,126 | 35,944 | 56,984 |
| Net Cash Flow | $-54,298 | $78,400 | $18,182 | $-21,040 | $19,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | 70,520 | 48,870 | 17,785 | 33,453 | 28,021 |
| Capital Expenditure | -10,159 | -14,514 | -19,266 | -24,709 | -40,295 |
| Free Cash Flow | 60,361 | 34,356 | -1,481 | 8,744 | -12,274 |